| Literature DB >> 25174966 |
Urh Groselj1, Mojca Zerjav Tansek1, Andraz Smon1, Natalija Angelkova2, Dana Anton3, Ivo Baric4, Maja Djordjevic5, Lindita Grimci6, Maria Ivanova7, Adil Kadam8, Vjosa Mulliqi Kotori9, Hajrija Maksic10, Oana Marginean11, Otilia Margineanu12, Olivera Milijanovic13, Florentina Moldovanu14, Mariana Muresan15, Simona Murko1, Michaela Nanu14, Barbka Repic Lampret1, Mira Samardzic13, Vladimir Sarnavka16, Aleksei Savov7, Maja Stojiljkovic17, Biljana Suzic18, Radka Tincheva8, Husref Tahirovic19, Alma Toromanovic20, Natalia Usurelu21, Tadej Battelino22.
Abstract
The aim of our study was to assess the current state of newborn screening (NBS) in the region of southeastern Europe, as an example of a developing region, focusing also on future plans. Responses were obtained from 11 countries. Phenylketonuria screening was not introduced in four of 11 countries, while congenital hypothyroidism screening was not introduced in three of them; extended NBS programs were non-existent. The primary challenges were identified. Implementation of NBS to developing countries worldwide should be considered as a priority.Entities:
Keywords: Newborn screening; Southeastern Europe; Survey
Mesh：
Year: 2014 PMID： 25174966 DOI： 10.1016/j.ymgme.2014.07.020
Source DB: PubMed Journal: Mol Genet Metab ISSN： 1096-7192 Impact factor: 4.797